For information on supporting the Orlando Dermatology Aesthetic & Clinical conference, contact Luciana Halliday at (646) 453-5717 or luciana.halliday@sanovaworks.com
Attendee Testimonials
ODAC is now accepting submissions for
Poster Presentations
Click here for more info
Downloads
Add ODAC '12
To Your Calendar
January 13-16, 2012
Rosen Shingle Creek
Orlando, FL
2012 Accreditation Statement
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the University of Louisville and SanovaWorks. The University of Louisville is accredited by the ACCME to provide continuing education for physicians.
DESIGNATION STATEMENT The University of Louisville Continuing Health Sciences Education office designates this educational activity for a maximum of 36.25 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
The Orlando Dermatology Aesthetic & Clinical Conference (Program #276100) is recognized by the American Academy of Dermatology for 36.25 AAD Recognized Category 1 CME Credit(s) and may be used toward the American Academy of Dermatology’s Continuing Medical Education Award.
Target Audience
This CME activity is designed for practicing dermatologists, dermatology residents and fellows, physician extenders in dermatology, and other physicians with an interest in dermatology.
Learning Objectives
Upon completion of this CME activity, participants will be able to:
Identify topical agents that target different aspects of acne pathogenesis; Describe the key pathogenic factors, adherence issues and solutions that promote optimal care in dermatitis; Recognize common histopathological skin disease and identify differential diagnosis; Identify the established and emerging best practices for diagnosing and prescribing treatment for psoriasis, including biologic therapies; Select and formulate the appropriate aesthetic treatment plan with neurotoxins and fillers for patients who seek improvement in facial appearance; Select and formulate the appropriate aesthetic treatment plan with laser and light-based energy therapy and technologies for patients who seek improvement in skin appearance; Diagnose pediatric dermatology conditions; Describe the epidemiology and diagnosis of rosacea; Assess patient expectations and select the course of modality for specific cosmetic results; Select the best method of treatment, field-directed, lesion-directed or combination therapy, to effectively manage AK and prevent the progression to SCC.






